High concentrations of ACTH are present in the neonatal circulation in response to birth stress. Since ACTH and P-lipotropin (PLPH) have a common precursor, and ACTH and P-endorphin .(PEP) are released in parallel in stressful situations, we measured plasma levels of PLPH and PEP in the first 24 hours of life.
Summary
High concentrations of ACTH are present in the neonatal circulation in response to birth stress. Since ACTH and P-lipotropin (PLPH) have a common precursor, and ACTH and P-endorphin .(PEP) are released in parallel in stressful situations, we measured plasma levels of PLPH and PEP in the first 24 hours of life.
Blood samples were taken from the umbilical cord at birth in 27 neonates, subdivided into four groups.
A further blood sample was obtained from the jugular vein after 30 min in nine cases (group A), after 6 hours in six (group B), and after 12 hours in six (group C), and after 24 hours in six (group D).
PLPH and PEP were measured by specific radioimmunoassays after silicic acid extraction of the plasma and Sephadex G-75 column chromatography.
In cord plasma, the mean (2S.E.) PLPH concentrations (pg/ Plasma PLPH concentrations determined at 30 min were 199.1 2 50.4, and these declined slightly in group C (after 12 hours:
168.2 + 30.2), but only showed a significant fall after 24 hours (88.5 f 27.0; P < 0.01 in comparison with the previous groups), reaching normal adult levels (71.7 + 25.1).
The pattern of PEP plasma levels (pg/ml) was very similar to that reported for PLPH. PEP plasma levels only showed a significant decrease after 24 hours (22.7 f 8.9; P < 0.01) when compared to the 12-hour age groud C. PEP cohcentratiot& at 30 min (76.1 + 47.7), 6 hours (68.6 f 29.3), and 12 hours (51.8 + 18.1) of life did not differ significantly from those found in mixed cord blood and were constantly higher than normal adult levels [24.5 rt 12.31.
Since the half-life of PLPH and PEP is respectively 45 and 37 min, the present data demonstrate that neonates are able to release PLPH and PEP during the first hours of life. Both these molecules may contribute to help the newborn in the transition from a close dependence on the mother, to an autonomous existence.
Speculation
Although the physiologic role of circulating PLPH and PEP has not been fully clarified, the presence of these peptides in neonatal plasma could represent an important analgesic factor in overcoming birth stress. Thus, an abnormal presence of these substances could be related to pathological situations. However, the source, the regulatory mechanisms and the biologic effects of circulating opioids in neonatal life are still unclear and require further investigation.
In particular, an early activation of the hypothalamus-pituitaryadrenal axis is necessary.
The significantly lower plasma cortisol levels found in newborn babies delivered by elective caesarian section, when compared with vaginally delivered neonates, demonstrates the relation between stimulation of the adrenal gland and the stressful events of labour and delivery (5, 35) .
Furthermore, it has recently been demonstrated that ACTH plasma levels are elevated during the first 6 hours of life, declining to normal adult values only 18 !;ours later (4, 20) . Accordingly, many authors have observed high plasma cortisol levels during the first 3 hours of life (1, 15, 16, 19, 33) , which decrease to normal adult levels after 24-48 hours.
The ability of neonates to secrete cortisol in response to ACTH stimulation (15, 18) or during insulin-induced hypoglycemia (1) and plasma ACTH suppression after dexamethasone, suggest that a Corticotropin Releasing Factor (CRF)-mediated cortisol-ACTH feedback mechanism is present in the neonatal period.
On the other hand, the ACTH molecule in the anterior pituitary is contained in a large molecular weight precursor, the pro-opiocortin (25) which also includes the aminoacid sequences of y-MSH and P-lipotropin (PLPH). In adults, ACTH, PLPH, and Pendorphin (PEP) (C-terminal residue of PLPH; PLPH 61-91) are secreted concomitantly in stressful situations (14, 21) . On this basis, and considering the very high amounts of ACTH (7, 11, 39) , PLPH and PEP (7, 9, 12, 13, 27) which circulate in the maternal and cord plasma at delivery, we investigated the changes occurring in PLPH and PEP plasma levels during the first few hours of life.
MATERIALS AND METHODS

SUBJECTS
After informed consent of the parents, 27 neonates, whose mothers were suspected of having contracted an infectious disease during pregnancy or who presented Rh incompatibility and in whom a blood sample was required for routine analysis, were considered in this study.
Gestational age ranged between 38 and 40 wk, the 1-min Agpar score between 8 and 10, and neonatal weight ranged from 2750 to 4000 g.
Mixed cord blood was collected in all cases at delivery and a second sample was taken from the jugular vein after 3 0 min in nine cases, after 6 hours in six, after 12 hours in six, and after 24 in the remaining six subjects. A further sample was also taken after 24 hours in three of the neonates from whom second samples had been taken at 6 hours, because of suspected (although not confirmed) hypocalcemia.
Heparinized blood samples of 3-4 ml, with the addition of 500 KIU Trasylol, were centrifuged immediately after collection at 2000 g at 4°C for 15 min; the plasma was stored at -70°C and assays were performed within 2 months.
PLASMA PURIFICATION
The transition from intra-to extra-uterine life is probably the most stressful situation that is met during our existence, and many Plasma, 1.5 to 3 ml, was extracted with 100-200 mg silicic acid adaptive phenomena are required to overcome this critical period. (100 mesh) on a rotary mixer for 1 hour. After washing with water and 1 N hydrochloric acid, the silicic acid was extracted twice with 1 ml of acetone-1 N HCl(9: 1).
The acetone mixture was dried under nitrogen, redissolved in 0.5 ml of 0.1 M acetic acid, 0.01% bovine serum albumin and applied to a Sephadex G-75 column (1.5 x 45 cm) eluted with the same solution. In these conditions, standard PLPH and PEP, added to dexamethasone-treated plasma, gave partition coefficients (Kav) of 0.54 for PLPH and 0.82 for PEP. In these conditions, two distinct peaks containing respectively PLPH and PEP were collected from each chromatographed plasma extract; 10-15 ml of eluates were pooled, freeze-dried, and redissolved in 0.4 ml of 0.05 M phosphate buffer pH 7.4, to be tested by radioimmunoassay (RIA) (8) .
Since the molecular weight of y-lipotropin (1-58 PLPH) is near 6300 and its tertiary structure is similar to PLPH, this peptide can be expected to elute in an intermediate position between PLPH and PEP peaks, and that an aliquot of endogenous yLPH will be present in the PLPH fraction to be measured by RIA.
Cold PLPH and PEP, 0.5 ng, added to 24 plasma samples, were recovered in the order of 51.2 f 7.4 and 57.5 f 8.1% (mean* S.D.), respectively. Twelve Sephadex columns were eluted simultaneously through a multi-channel peristaltic pump and I'25-/3LPH and P-EP were added to one plasma sample in order to monitor the recovery in each series of extraction and chromatography.
RIA
Synthetic PEP (Bachem Inc., Torrance, CA) and Human PLPH (donated by Prof. C. H. Li, San Francisco, CA) were used as standard and for labelling with I'25 using the Chloramine-T method.
Anti-human PEP rabbit serum (C-terminal) and anti-human LPH rabbit serum (N-terminal), both supplied by Prof. C. H. Li, were used at dilutions of 1 : 3400 and 1 : 5400, respectively.
Cross-reactivities of the antisera have been reported elsewhere (37, 38) .
Since YLPH probably cross-reacts completely with N-terminal anti-BLPH serum, yLPH present in the pooled BLPH fraction obtained by coli& chromatography Gay contribute to the amount of IR BLPH a~~a r e n t l v measured. Nevertheless, the IR materials present in this' fractiGn and tested with the above described PLPH RIA, will conventionally be referred to as PLPH.
Two dc uble-antibody RIAs were performed as described else: where (8) .
Sensitivity of the assays was 10 pg for PLPH and 4.5 pg for PEP. Intra-and inter-assay coefficients of variation were respectively 8.4 and 10.6 for PLPH and 7.6 and 11.2 for PEP. Figure 1 reports the plasma levels of PLPH, PEP and their molar ratio, found in the 27 neonates subdivided into four groups according to neonatal age, and respective cord blood concentrations. The mean (+ S.D.) PLPH concentrations in cord plasma in the four groups ranged from 219.5 + 84.5 to 241 + 43.3 pg/ml, while single values ranged from 102 to 342 pg/ml. Plasma concentrations in the neonates diminished from 199.1 f 50.4 pg/ml (range: 102-283 pg/ml) after 30 min, to 168.2 + 30.3 pg/ml (range: 105-310 pg/ml) after 12 hours, and 88.5 + 27.0 pg/ml (range: 140-294 pg/ml) after 24 hours. Only the levels found after this interval of time showed a significant difference ( P < 0.01) in comparison to both the respective cord plasma concentration and the plasma levels found in the group tested after 12 hours ( P < 0.05).
RESULTS
The mean ( f S.D.) PEP concentration in cord plasma varied in the four groups from 70.2 f 8.2 to 54.6 f 14.4 pg/ml, while single values ranged between 14 and 101 pg/ml. Plasma levels of PEP in the neonates decreased from 76.1 + 47.7 pg/ml (range: 18-176 pg/ml) at 30 min, to 66.6 + 29.3 pg/ml (range: 35-109 pg/ml) at 6 hours, 5 1.8 + 18.1 pg/ml (range: 33-79 pg/ml) at 12 hours, and 27.7 + 8.9 pg/ml (range: 17-38 pg/ml) after 24 hours. These last values were significantly lower ( P < 0.01) than the respective PEP cord plasma concentrations (54.5 + 14.4 pg/ml) and those found in neonates after 12 hours ( P < 0.05).
The PLPH/PEP ratio on a molar basis ranged from 1.12 + 0.37 to 1.37 + 0.60 in the four groups of cord plasma, and in the neonatal plasma from 1.22 + 0.63 to 1.13 + 0.36. A significant correlation between PLPH and PEP plasma levels was found both in cord plasma (r = 0.492; P < 0.01) and in neonatal plasma (r = 0.780; P < 0.001).
Individual plasma levels of the two opioids obtained in the three cases in which two successive samples were taken, are reported in Table 1 . These results support the above reported PLPH and PEP patterns in the early hours of neonatal life.
DISCUSSION
With the exception of Goland et al. (13) who found constantly normal levels of PEP-like imrnunoreactive materials, plasma concentrations of PEP have been shown to increase progressively during pregnancy, the highest levels being found at term (7, 12) . A further increase has been observed in the first and second stages of labour (7, 9, 13) , when PLPH plasma levels also rise in parallel.
High concentrations of both opioids have been demonstrated in mixed cord plasma (7, 9, 12, 13) with a positive gradient from the umbilical artery to vein (36) .
The origin of these opioids in the maternal circulation could be attributed not only to the pituitary, but also to the placenta, since the presence (1 1, 28 ) and the in vitro synthesis and release (23) of both PLPH and PEP have been demonstrated by this endocrine organ. Moreover, in addition to the ability of the fetal pituitary to secrete ACTH (2) , immunocytochemical studies have recently demonstrated that fetal anterior pituitary granules contain PLPH, PEP and probably the proopiocortin (22) .
The presence in the neonatal circulation, up to the twelfth hour of life, of elevated PLPH and PEP values which are similar to those found in cord plasma, seems to indicate that the neonate is able to release these peptides. In fact, the half-life of PLPH and PEP, calculated as time of disappearance from the plasma, is 45 and 37 minutes, respectively (10) . Therefore, if the opioid peptides found in neonates originate from the placental tissue or maternal plasma, it may be expected that they will have disappeared from the circulation after 6 hours.
On the other hand, these data are in perfect agreement with previous demonstrations of raised ACTH levels during the first 6 hours of life (4, 20) , and offer further support to the concept that ACTH, PLPH, and PEP are released in parallel in stressful situations (14, 25) .
The hypothesis that not only delivery, but also the first hours of extrauterine life may represent a stressful situation, is further supported by the marked metabolic changes occurring at this time, such as hypoglycemia (6), hyponatremia (32), hypocalcemia (30), loss of liquids, etc. These observations also support the supposition that the adrenal hyperactivity found in this critical period is sustained (1, 18, 19, 23) by the high levels of ACTH. On the other hand, the demonstration that PEP stimulates corticosterone release by rat adrenal cells in vitro (3) , and that PLPH induces aldosterone production by human adrenal cells in culture (26) , suggest that PLPH and PEP may also be involved in the adrenal stimulation occurring in the postnatal period.
However, the physiologic significance of the high PLPH and PEP levels at birth and during the first few hours of life still remains unclear.
In consideration of the fact that a significant amount of pituitary hormonal secretion may reach the central nervous system by backflow (29), we can assume [bearing in mind the possible extrapituitary sources of these peptides (3) ], that circulating levels could also partially reflect their central effects. Therefore, the three times higher than normal PEP levels found in early postnatal life could play a role in mediating neonatal analgesia which is probably fundamental in overcoming the painful situation of delivery and birth. In fact, it has been shown that PEP in pharmacologic doses possesses a marked analgesic activity when administered both intraventricularly (24) and peripherally (34) in animals, and more recently pain relief has been demonstrated in humans by intravenous injection of PEP (17) .
In conclusion, the present data demonstrate that neonates are able to release PLPH and PEP during the first hours of life. Both these molecules may contribute to help the neonate in the transition from a close dependence on the mother to an autonomous existence.
